Literature DB >> 26331854

Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure.

Rashi Sehgal1, Sharda Patra2, Paul David1, Ashish Vyas1, Arshi Khanam1, Syed Hissar1, Ekta Gupta3, Guresh Kumar1, Shyam Kottilil4, Rakhi Maiwall5, Shiv Kumar Sarin1,5, Nirupama Trehanpati1.   

Abstract

UNLABELLED: Acute viral hepatitis resulting due to hepatitis E viral infection (AVH-E) is often serious in pregnancy and could result in acute liver failure (ALF). The role of monocytes and macrophages (mono-macs) in the pathogenesis of AVH-E and development of ALF-E in pregnancy is unclear. We investigated the functions of mono-macs in pregnant (P), AVH-E (n = 44), ALF-E (n = 12), healthy controls (HC; n = 20) and compared with nonpregnant (NP) AVH-E (n = 10), ALF-E (n = 5), and HC (n = 10). We also recruited non-hepatitis E virus-related pregnant (P), ALF-NE (n = 5) and non-pregnant (NP), ALF-NE (n = 12) patients with ALF. Mono-macs, dendritic cell (DC) phenotypes, and Toll-like receptor (TLR) expressions were studied by flow cytometry and reverse-transcriptase polymerase chain reaction. Mono-macs functionality was determined by analyzing their phagocytic activity and reactive oxygen species (ROS) generation by using flow cytometry. Frequency of mono-macs and DCs was increased during HEV infection compared to HC (P < 0.001). Macrophages were increased (P < 0.002) in ALF-E(P) compared to ALF-NE(P). The macrophage phagocytic activity and Escherichia coli-induced ROS production was significantly impaired in ALF-E(P) compared to AVH-E(P) (P < 0.001), ALF-E(NP), and ALF-NE(P) patients (P < 0.02). TLR3 and TLR9 expression and downstream MYD88 signalling molecules IRF3 and IRF7 were significantly down-regulated in ALF-E(P) (P < 0.00) compared to AVH-E(P) and ALF-NE(P).
CONCLUSION: Functionality of mono-macs is impaired in pregnant ALF-E patients compared to AVH-E(P). Reduced TLR3 and TLR7 expression and TLR downstream-signaling molecules in pregnant ALF-E patients suggests inadequate triggers for the innate immune responses contributing to development and severity of ALF-E. Studies using TLR agonists to activate mono-macs may be of use and in vitro studies should be undertaken using patient samples.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26331854     DOI: 10.1002/hep.28143

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

Review 1.  Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

2.  NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Authors:  Vikram Thakur; Radha Kanta Ratho; Mini P Singh; Yogesh Chawla; Sunil Taneja
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

3.  Modulation of SOCS3 Levels via STAT3 and Estrogen-ERαp66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.

Authors:  Harini Sooryanarain; C Lynn Heffron; Hassan M Mahsoub; Anna M Hassebroek; Bo Wang; Debin Tian; S Ansar Ahmed; Xiang-Jin Meng
Journal:  J Virol       Date:  2022-09-14       Impact factor: 6.549

4.  Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.

Authors:  Yang Li; Peifa Yu; Amy L Kessler; Jingyi Shu; Xiaoyan Liu; Zhaochao Liang; Jiaye Liu; Yunlong Li; Pengfei Li; Ling Wang; Yining Wang; Zhongren Ma; Aixia Liu; Ling Wang; Marco J Bruno; Robert A de Man; Maikel P Peppelenbosch; Sonja I Buschow; Lin Wang; Yijin Wang; Qiuwei Pan
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

Review 5.  Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure.

Authors:  Chong Chen; Shu-Ye Zhang; Liang Chen
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

Review 6.  Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Authors:  Mhairi C Donnelly; Peter C Hayes; Kenneth J Simpson
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 7.  Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.

Authors:  Anil C Anand; Bhaskar Nandi; Subrat K Acharya; Anil Arora; Sethu Babu; Yogesh Batra; Yogesh K Chawla; Abhijit Chowdhury; Ashok Chaoudhuri; Eapen C Eapen; Harshad Devarbhavi; RadhaKrishan Dhiman; Siddhartha Datta Gupta; Ajay Duseja; Dinesh Jothimani; Dharmesh Kapoor; Premashish Kar; Mohamad S Khuroo; Ashish Kumar; Kaushal Madan; Bipadabhanjan Mallick; Rakhi Maiwall; Neelam Mohan; Aabha Nagral; Preetam Nath; Sarat C Panigrahi; Ankush Pawar; Cyriac A Philips; Dibyalochan Prahraj; Pankaj Puri; Amit Rastogi; Vivek A Saraswat; Sanjiv Saigal; Akash Shukla; Shivaram P Singh; Thomas Verghese; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-04-28

Review 8.  Acute-on-chronic liver failure: terminology, mechanisms and management.

Authors:  Shiv K Sarin; Ashok Choudhury
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

Review 9.  Zoonotic Hepatitis E Virus: An Ignored Risk for Public Health.

Authors:  Yuchen Nan; Chunyan Wu; Qin Zhao; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-12-04       Impact factor: 5.640

Review 10.  Hepatitis E Pathogenesis.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Sabine Chapuy-Regaud; Nassim Kamar; Jacques Izopet
Journal:  Viruses       Date:  2016-08-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.